His scientific interests lie mostly in Gerontology, Alzheimer's disease, Cognition, Demography and Cognitive decline. He interconnects Epidemiology, Cohort study, Incidence, Confidence interval and Risk factor in the investigation of issues within Gerontology. His Alzheimer's disease research is multidisciplinary, incorporating elements of Central nervous system disease, Apolipoprotein E and Dementia.
His biological study spans a wide range of topics, including Genetics, Genome-wide association study, Single-nucleotide polymorphism and Age of onset. His Cognition study combines topics in areas such as Developmental psychology, Proportional hazards model, Standard score and Stroke. Denis A. Evans has researched Cognitive decline in several fields, including Center for Epidemiologic Studies Depression Scale, Trans fat, Cognitive disorder and Cyanocobalamin.
Denis A. Evans mostly deals with Gerontology, Cognition, Cognitive decline, Alzheimer's disease and Disease. The study incorporates disciplines such as Incidence, Epidemiology, Cohort study, Demography and Confidence interval in addition to Gerontology. His study in Cognition is interdisciplinary in nature, drawing from both Developmental psychology and Prospective cohort study.
His work in Alzheimer's disease addresses issues such as Dementia, which are connected to fields such as Psychiatry. His work carried out in the field of Disease brings together such families of science as Longitudinal study, Physical therapy and Genome-wide association study. In his study, which falls under the umbrella issue of Genome-wide association study, Genetics is strongly linked to Apolipoprotein E.
His primary areas of study are Cognitive decline, Cognition, Genome-wide association study, Gerontology and Alzheimer's disease. His research in Cognitive decline intersects with topics in Demography, Cognitive aging and Population sample. His Cognition research is multidisciplinary, relying on both Developmental psychology, Prospective cohort study, Mediterranean diet and Quartile.
His work deals with themes such as Apolipoprotein E, Disease and Genetic association, which intersect with Genome-wide association study. He works mostly in the field of Gerontology, limiting it down to concerns involving Cohort study and, occasionally, Cohort and Hazard ratio. His Alzheimer's disease research includes elements of Odds ratio, TREM2, Cognitive reserve and Allele frequency.
Denis A. Evans focuses on Genome-wide association study, Genetics, Alzheimer's disease, Single-nucleotide polymorphism and Dementia. His studies deal with areas such as SNP, Genetic association and Medical genetics as well as Genome-wide association study. His Genetics study deals with Apolipoprotein E intersecting with Locus and Longevity.
His studies in Alzheimer's disease integrate themes in fields like Gerontology, Cognition, Allele frequency, TREM2 and Cognitive decline. Denis A. Evans performs integrative study on Gerontology and Social relation in his works. The various areas that Denis A. Evans examines in his Dementia study include Odds ratio, Incidence and Hazard ratio, Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Liesi E. Hebert;Paul A. Scherr;Julia L. Bienias;David A. Bennett.
JAMA Neurology (2003)
Two Shorter Forms of the CES-D Depression Symptoms Index:
Frank J. Kohout;Lisa F. Berkman;Denis A. Evans;Joan Cornoni-Huntley.
Journal of Aging and Health (1993)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.
Liesi E. Hebert;Jennifer Weuve;Paul A. Scherr;Denis A. Evans.
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease
Robert S. Wilson;Carlos F. Mendes de Leon;Lisa L. Barnes;Julie A. Schneider.
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
Zoe Arvanitakis;Robert S. Wilson;Julia L. Bienias;Denis A. Evans.
JAMA Neurology (2004)
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Marthac Clare Morris;Denis A. Evans;Julia L. Bienias;Christine C. Tangney.
JAMA Neurology (2003)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Natural history of mild cognitive impairment in older persons.
D. A. Bennett;R. S. Wilson;J. A. Schneider;D. A. Evans.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: